Opus Genetics, Inc.
IRD· Nasdaq
IRDOpus Genetics, Inc.
Filed May 4, 2018 · 10-Q · 34 days after period end · 0001140361-18-021763
| Metric | Q1 2018 | Q1 2017 | Q1 2016 | Q1 2015 |
|---|---|---|---|---|
| Net Income | -$2.07M | -$21.61M | -$4.15M | -$4.27M |
| EPS Diluted | -$0.79 | -$0.91 | -$0.20 | -$0.02 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Opus Genetics, Inc. · CIK 1228627 · Engraved from SEC EDGAR
ended Mar 31, 2018 · filed May 4, 2018 · 34 d after period end
